SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 222 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.12 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $133,000 | +1230.0% | 5,000 | +900.0% | 0.01% | +500.0% |
| Q3 2020 | $10,000 | -9.1% | 500 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $11,000 | +37.5% | 500 | 0.0% | 0.00% | – |
| Q1 2020 | $8,000 | -27.3% | 500 | 0.0% | 0.00% | -100.0% |
| Q4 2019 | $11,000 | -15.4% | 500 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $13,000 | -18.8% | 500 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $16,000 | -5.9% | 500 | 0.0% | 0.00% | -50.0% |
| Q1 2019 | $17,000 | -80.9% | 500 | -81.5% | 0.00% | -75.0% |
| Q4 2018 | $89,000 | +4350.0% | 2,700 | -18.2% | 0.01% | – |
| Q1 2018 | $2,000 | -77.8% | 3,300 | -0.4% | 0.00% | – |
| Q4 2017 | $9,000 | -96.6% | 3,312 | -73.4% | 0.00% | -100.0% |
| Q3 2017 | $268,000 | +14.0% | 12,437 | +45.0% | 0.01% | +11.1% |
| Q2 2017 | $235,000 | +197.5% | 8,577 | -15.1% | 0.01% | +200.0% |
| Q1 2017 | $79,000 | – | 10,100 | +818.2% | 0.00% | – |
| Q4 2016 | $0 | -100.0% | 1,100 | -56.0% | 0.00% | – |
| Q3 2016 | $8,000 | -55.6% | 2,500 | -14.0% | 0.00% | -100.0% |
| Q2 2016 | $18,000 | -83.5% | 2,906 | -80.6% | 0.00% | -85.7% |
| Q1 2016 | $109,000 | -60.9% | 15,006 | -36.6% | 0.01% | -53.3% |
| Q4 2015 | $279,000 | – | 23,684 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ASHFORD CAPITAL MANAGEMENT INC | 921,962 | $33,402,683 | 5.00% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 423,500 | $15,326,465 | 4.28% |
| ARMISTICE CAPITAL, LLC | 4,350,000 | $157,600,500 | 2.27% |
| S&T BANK/PA | 223,775 | $8,107 | 1.46% |
| Aristotle Capital Boston, LLC | 1,155,149 | $41,851,071 | 1.29% |
| Tributary Capital Management, LLC | 353,671 | $12,813,500 | 1.19% |
| Bridge City Capital, LLC | 62,790 | $2,274,882 | 1.14% |
| RICE HALL JAMES & ASSOCIATES, LLC | 551,285 | $19,973,056 | 1.14% |
| Intrinsic Edge Capital Management LLC | 289,704 | $10,495,976 | 1.05% |
| Parkman Healthcare Partners LLC | 131,878 | $4,777,940 | 1.04% |